Ronald Jay Kahn is a Dover, Delaware based male podiatrist who is specialized in Podiatry. Active license number of Ronald Jay Kahn for Podiatry is E1-0000084 in Delaware. Ronald Jay Kahn is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Ronald Jay Kahn speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
D.P.M.
Gender:
Male
Practice Address:
642 S Queen St, Suite #103, Dover, Delaware, 19904-3506
Phone:
302-674-9255
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1710987094
NPI Enumeration Date:
28 Jul, 2005
NPI Last Update On:
21 Sep, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ronald Jay Kahn are as mentioned below.
License Number
Specialization
State
Status
E1-0000084
Podiatry
Delaware
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
642 S Queen St, Suite #103 Dover, Delaware
Zip:
19904-3506
Phone Number:
302-674-9255
Fax Number:
--
Patients can reach Ronald Jay Kahn at 642 S Queen St, Suite #103, Dover, Delaware or can call to book an appointment on 302-674-9255. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.